Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.38 |
| ▸ | CCNT1 | O60563 | 6/20 | 0.36 |
| ▸ | CDK9 | P50750 | 6/20 | 0.36 |
| ▸ | KDM1A | O60341 | 2/20 | 0.34 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.33 |
| ▸ | ESR1 | P03372 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | CASP3 | P42574 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.32 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.32 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.32 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.32 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.31 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.31 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | RARA | P10276 | 1/20 | 0.30 |
| ▸ | RARB | P10826 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8932708 | 0.92 | CCNT1 (0.37) | NAAACCNT1CDK9ESR1NPC1 | |
| SCHEMBL11026629 | 0.90 | CCNT1 (0.37) | CCNT1CDK9ESR1PTGDR2L3MBTL1 | |
| SCHEMBL8939271 | 0.89 | CCNT1 (0.38) | CCNT1CDK9ESR1NPC1CASP3 | |
| SCHEMBL15381642 | 0.89 | NAAA (0.44) | NAAACCNT1CDK9ESR1FGFR1 | |
| SCHEMBL11023774 | 0.89 | CCNT1 (0.37) | CCNT1CDK9ESR1PTGDR2 | |
| SCHEMBL14766715 | 0.88 | NAAA (0.39) | NAAACCNT1CDK9FFAR4PTGDR2 | |
| SCHEMBL8939277 | 0.87 | CCNT1 (0.37) | CCNT1CDK9ESR1 | |
| SCHEMBL8939274 | 0.87 | CCNT1 (0.37) | CCNT1CDK9ESR1 | |
| SCHEMBL15381704 | 0.86 | NAAA (0.41) | NAAACCNT1CDK9ESR1FGFR1 | |
| SCHEMBL8939261 | 0.86 | CCNT1 (0.41) | NAAACCNT1CDK9ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2484658-B1 | LIQUID CRYSTALLINE COMPOUND WITH NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION USING SAME, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORP (JP) | 2017-12-06 | — | — | EP | disclosed |
| US-9109157-B2 | Liquid crystal compound having negative dielectric anisotropy, liquid crystal composition and liquid crystal display device using the same | JNC CORPORATION (JP) | 2015-08-18 | — | — | US | disclosed |
| US-9109157-B2 | Liquid crystal compound having negative dielectric anisotropy, liquid crystal composition and liquid crystal display device using the same | JNC CORPORATION (JP) | 2015-08-18 | — | — | US | disclosed |
| US-9109157-B2 | Liquid crystal compound having negative dielectric anisotropy, liquid crystal composition and liquid crystal display device using the same | JNC CORPORATION (JP) | 2015-08-18 | — | — | US | disclosed |
| EP-2484658-A1 | LIQUID CRYSTALLINE COMPOUND WITH NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION USING SAME, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC Corporation (JP) | 2012-08-08 | — | — | EP | disclosed |
| US-20120190897-A1 | LIQUID CRYSTAL COMPOUND HAVING NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | JNC PETROCHEMICAL CORPORATION (JP) | 2012-07-26 | — | — | US | disclosed |
| US-20120190897-A1 | LIQUID CRYSTAL COMPOUND HAVING NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | JNC PETROCHEMICAL CORPORATION (JP) | 2012-07-26 | — | — | US | disclosed |
| US-20120190897-A1 | LIQUID CRYSTAL COMPOUND HAVING NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | JNC PETROCHEMICAL CORPORATION (JP) | 2012-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120190897-A1 | LIQUID CRYSTAL COMPOUND HAVING NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | H1-0, EFHD2, CCND2 | NAAA 3360/4885CCNT1 7/4885CDK9 813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.